[Asia Economy Reporter Seo So-jeong] Dongkook Pharmaceutical held its 53rd regular general meeting of shareholders on the 19th and reappointed Vice Chairman Kwon Ki-beom as an inside director. The term is three years.


Vice Chairman Kwon is the eldest son of the late Chairman Kwon Dong-il, the founder of Dongkook Pharmaceutical.


On the same day, Dongkook Pharmaceutical decided to add the business of manufacturing, importing, and selling veterinary pharmaceuticals.



During the agenda review, a proposal to pay a dividend of 180 KRW per common share, distributing a total cash dividend of 8,049,370,000 KRW, was passed.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing